Advion Forms Distribution Agreement for Spain, Portugal and South America
News Feb 15, 2013
The partnership allows KONIK to leverage its 35 year history in scientific instrumentation business and sell, service and support Advion’s Compact Mass Spectrometer (CMS) systems in Spain, Portugal and South American countries (with the exception of Brazil).
“The expression CMS has seen tremendous growth in its first year, and our strong global distribution network has played a key role in identifying regional scientific research leaders as well as to promote the product in the most valuable and dynamic applications,” says Vijay Gupta, Vice President International Business Development and Support. “We have received significant market pull from Spain, Portugal and South America, and KONIK is a well-respected partner in these areas allowing prospects and customers to have a local support network available to assist them in a timely manner. Konik’s long history in LC, GC and MS innovation, rounded by their recently patented Multidimensional HPLC+GC-MS platform, as well as their superb knowledge of organic and analytical chemistry make them a uniquely qualified partner”.
The distributor partnership agreement allows KONIK exclusive marketing, sales, service and support of the expression CMS systems with added support from Advion’s European team and global staff.
Arrow Poison Potential Male Birth ControlNews
Women have many options for oral contraceptives that are safe, effective and reversible, but despite decades of research, men have none. Now, scientists report a rat study that shows they finally have a good lead for a male birth control pill. It's based on ouabain, a plant extract that African warriors and hunters traditionally used as a heart-stopping poison on their arrows.READ MORE
Robust Multiplex Mass Spectrometric Assay for Screening Small-Molecule InhibitorsNews
A new original research article presents a fast, sensitive, and robust methodology for screening small molecule inhibitors against CD73/Ecto-5'-Nucleotidase, a promising target for developing anti-cancer drugs.READ MORE